13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 96 holding rows worth $265,608,000.
- Accession
- 0001387131-21-002361
- Filer
- CIK 1746382
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 98 entries on the cover page, a total value of $265,608,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $265,608,000 with VALUE read as thousands by filing date, 13F file number 028-20820. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 2,068,530 | $13,425,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 822,009 | $6,732,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 303,174 | $6,276,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 902,633 | $6,237,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 276,719 | $6,008,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 263,596 | $5,862,000 | thousands by filing date | |
| GENPREX INC | 372446104 | COM | 1,409,785 | $5,851,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 2,731,974 | $5,819,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 261,209 | $5,616,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,682,535 | $5,149,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 361,930 | $5,107,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 148,743 | $4,952,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 153,348 | $4,876,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 432,563 | $4,858,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITION CO | G3166W106 | COM CL A | 400,000 | $4,340,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 218,650 | $4,324,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 400,000 | $4,264,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 239,520 | $4,196,000 | thousands by filing date | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 61,991 | $4,163,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 11,200 | $4,144,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 16,200 | $4,141,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 293,917 | $4,065,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T107 | COM | 388,845 | $3,966,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 134,233 | $3,866,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 216,925 | $3,770,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 185,854 | $3,747,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 244,155 | $3,733,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 77,622 | $3,585,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 262,465 | $3,541,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 185,552 | $3,338,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 205,799 | $3,264,000 | thousands by filing date | |
| TINGO GROUP INC | 55328R109 | COM | 1,533,425 | $3,190,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 150,150 | $3,140,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 465,589 | $3,110,000 | thousands by filing date | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 26,144 | $3,105,000 | thousands by filing date | |
| SCYNEXIS INC | 811292200 | COM NEW | 400,000 | $3,060,000 | thousands by filing date | |
| ORBITAL ENERGY GROUP INC | 68559A109 | COM | 1,353,995 | $2,965,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 752,634 | $2,928,000 | thousands by filing date | |
| ALPHA HEALTHCARE ACQUISTN CO | 020751202 | UNIT 10/01/2023 | 275,000 | $2,907,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 250,000 | $2,843,000 | thousands by filing date | |
| NANO DIMENSION LTD | 63008G203 | SPONSORD ADS NEW | 304,600 | $2,772,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 250,000 | $2,668,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 250,000 | $2,618,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T116 | UNT | 254,000 | $2,609,000 | thousands by filing date | |
| FS DEV CORP | 303020101 | COM CL A | 234,000 | $2,574,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 197,500 | $2,427,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 225,000 | $2,396,000 | thousands by filing date | |
| CM LIFE SCIENCES INC | 18978W208 | UNIT 09/01/2025 | 200,000 | $2,320,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 73,991 | $2,289,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 99,661 | $2,282,000 | thousands by filing date | |
| Axonics | 88875G101 | COM | 1,077,883 | $2,177,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 267,753 | $2,107,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 175,067 | $2,089,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 76,484 | $2,085,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 133,951 | $2,074,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 200,000 | $2,060,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 31,512 | $2,055,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 5,500 | $2,033,000 | thousands by filing date | |
| ONCTERNAL THERAPEUTICS INC | 68236P107 | COM | 411,667 | $2,017,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 9,321 | $1,999,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 571,026 | $1,999,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 93,261 | $1,997,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 313,745 | $1,980,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 299,890 | $1,940,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 458,589 | $1,899,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 588,992 | $1,897,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 250,000 | $1,863,000 | thousands by filing date | |
| OPENDOOR TECHNOLOGIES INC | 683712111 | *W EXP 12/18/202 | 240,000 | $1,853,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 273,703 | $1,793,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 851,852 | $1,772,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 62,962 | $1,771,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 101,994 | $1,694,000 | thousands by filing date | |
| SWITCHBACK ENERGY ACQUISTN C | 87105M110 | W EXP 07/25/202 | 105,000 | $1,619,000 | thousands by filing date | |
| YUMANITY THERAPEUTICS INC | 98872L102 | COM | 108,695 | $1,478,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 130,000 | $1,412,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 120,000 | $1,373,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120202 | COM NEW | 332,258 | $1,289,000 | thousands by filing date | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 108,794 | $1,252,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 100,000 | $1,114,000 | thousands by filing date | |
| 9 METERS BIOPHARMA INC | 654405109 | COM | 1,264,994 | $1,087,000 | thousands by filing date | |
| Roth Ch Acquisition II Co | 778673202 | Unit | 100,000 | $1,040,000 | thousands by filing date | |
| CNS PHARMACEUTICALS INC | 18978H102 | COM | 534,148 | $951,000 | thousands by filing date | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 300,000 | $810,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L114 | *W EXP 12/24/202 | 215,250 | $710,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T115 | *W EXP 03/05/202 | 500,000 | $495,000 | thousands by filing date | |
| HALL OF FAME RESORT & ENTMT | 40619L110 | *W EXP 07/01/202 | 1,000,000 | $372,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 64,666 | $365,000 | thousands by filing date | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 97,467 | $281,000 | thousands by filing date | |
| KUBIENT INC COM USD0.00001 | 50116V107 | COM | 42,269 | $236,000 | thousands by filing date | |
| AMPLITUDE HLTHCRE AQUSTIN CO | 03212A113 | *W EXP 12/01/202 | 162,500 | $236,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F138 | *W EXP 04/20/202 | 400,000 | $186,000 | thousands by filing date | |
| SHAPEWAYS HOLDIN | G3770A110 | EQUITY WRT | 200,000 | $168,000 | thousands by filing date | |
| VENUS CONCEPT INC | 92332W105 | COM | 93,643 | $162,000 | thousands by filing date | |
| PYXIS TANKERS INC | Y71726106 | COM | 10,000 | $142,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 24,912 | $130,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 10,000 | $128,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-21-002361 | this filing | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001387131-21-005329 | base | 2021-05-05 | acceptance time not in the bulk data set |